Smallpox Vaccine Clinical Trials
- Dose On Safety, Tolerability, and Immunogenicity of ACAM2000 Smallpox Vaccine in Adults With Previous Smallpox Vaccination
ClinicalTrials.gov Identifier: NCT00053482 - Active, not recruiting
Smallpox
- Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination
ClinicalTrials.gov Identifier: NCT00053495 - Active, not recruiting
Smallpox
- Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults without Previous Smallpox Vaccination
ClinicalTrials.gov Identifier: NCT00053508 - Active, not recruiting
Smallpox
- Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers
ClinicalTrials.gov Identifier: NCT00103584 - Active, not recruiting
Smallpox
- Safety and Immunogenicity of Smallpox Vaccine MVA-BN
ClinicalTrials.gov Identifier: NCT00082446 - Active, not recruiting
Smallpox
- Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax®
ClinicalTrials.gov Identifier: NCT00042094 - Active, not recruiting
Smallpox
- Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults
ClinicalTrials.gov Identifier: NCT00079820 - Completed
Smallpox
- Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults
ClinicalTrials.gov Identifier: NCT00258947 - Active, not recruiting
Smallpox; Poxvirus Infection
- ACAM 3000 MVA at Harvard Medical School
ClinicalTrials.gov Identifier: NCT00133575 - Active, not recruiting
Variola major (smallpox)
- APSV in vaccinia naive adults
ClinicalTrials.gov Identifier: NCT00050518 - Completed
Smallpox
- Human Immune Response to Smallpox Vaccine
ClinicalTrials.gov Identifier: NCT00068198 - Completed
Smallpox
- Immune Responses to Smallpox Vaccination
ClinicalTrials.gov Identifier: NCT00325975 - Recruiting
Smallpox Vaccine
- A Double-Blind, Placebo-Controlled, Dose-Finding, Phase 2 Study to Assess the Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Modified Vaccinia Ankara Smallpox Vaccine
ClinicalTrials.gov Identifier: NCT00466245 - Active, not recruiting
Smallpox
- A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults
ClinicalTrials.gov Identifier: NCT00026611 - Completed
Smallpox
- Dressing Preparation Comparison for Smallpox Vaccination Sites
ClinicalTrials.gov Identifier: NCT00063856 - Completed
Smallpox
- Dryvax vaccine immunogenicity in previously vaccinated
ClinicalTrials.gov Identifier: NCT00050505 - Completed
Smallpox
- A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers
ClinicalTrials.gov Identifier: NCT00002261 - Completed
HIV Infections
- VHA Clinicians and Bioterror Events: Interactive Web-Based Learning
ClinicalTrials.gov Identifier: NCT00123396 - Active, not recruiting
Smallpox; Anthrax
- Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects
ClinicalTrials.gov Identifier: NCT00189969 - Completed
Smallpox
- MVA Post-Event: Administration Timing and Boost Study
ClinicalTrials.gov Identifier: NCT00437021 - Recruiting
Smallpox; Variola Major (Smallpox)
- A Randomized, Double-Blind, Placebo-Controlled Study on Immunogenicity and Safety of MVA-BN (IMVAMUNE™) Smallpox Vaccine in Healthy Subjects
ClinicalTrials.gov Identifier: NCT00316524 - Completed
Smallpox
- Assessment of dryvax in previously vaccinated adults
ClinicalTrials.gov Identifier: NCT00032708 - Completed
Smallpox
- Vaccinia virus vaccine (APSV) in vaccinia- naive subjects: PILOT
ClinicalTrials.gov Identifier: NCT00038987 - Completed
Smallpox
- Dose-Finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.
ClinicalTrials.gov Identifier: NCT00189956 - Completed
Smallpox
- Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients
ClinicalTrials.gov Identifier: NCT00316589 - Recruiting
HIV Infections
- A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis
ClinicalTrials.gov Identifier: NCT00316602 - Recruiting
Atopic Dermatitis
- Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine
ClinicalTrials.gov Identifier: NCT00152802 - Active, not recruiting
transplant
- A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)
ClinicalTrials.gov Identifier: NCT00000767 - Completed
HIV Infections
- Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
ClinicalTrials.gov Identifier: NCT00013871 - Active, not recruiting
HIV Infections; Hepatitis B; Measles; Pneumococcal Infections; Pertussis
- Study of Anti-HIV Therapy Intensification
ClinicalTrials.gov Identifier: NCT00034086 - Active, not recruiting
HIV Infections
- Kidney Transplants in People with HIV Infection
ClinicalTrials.gov Identifier: NCT00023478 - Active, not recruiting
HIV Infections; End-Stage Renal Disease
- Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age
ClinicalTrials.gov Identifier: NCT00242424 - Active, not recruiting
Inactivated Influenza Vaccine
- Safety Study of MVA Smallpox Vaccine in HIV-Positive Subjects Who Are Vaccinia Naive
ClinicalTrials.gov Identifier: NCT00282581 - Terminated
HIV Infections; Smallpox
- Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Diphtheria, Tetanus & Pertussis Vaccine (DTaP) Vaccine & a Haemophilus Influenza Type B (Hib) Vaccine in Healthy Children 15 m of Age
ClinicalTrials.gov Identifier: NCT00197236 - Active, not recruiting
Hepatitis A
- Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination
ClinicalTrials.gov Identifier: NCT00143780 - Active, not recruiting
Bone Marrow Transplant
- A Study to Test the Safety of Three Experimental HIV Vaccines
ClinicalTrials.gov Identifier: NCT00000946 - Active, not recruiting
HIV Infections; HIV Seronegativity
- Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults
ClinicalTrials.gov Identifier: NCT00061243 - Active, not recruiting
HIV Infections
- Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella, and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month Old Children
ClinicalTrials.gov Identifier: NCT00312858 - Active, not recruiting
Hepatitis A
- Recombinant CMV gB Vaccine in Postpartum Women
ClinicalTrials.gov Identifier: NCT00125502 - Active, not recruiting
Cytomegalovirus Infections
- Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer
ClinicalTrials.gov Identifier: NCT00009958 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants
ClinicalTrials.gov Identifier: NCT00000829 - Active, not recruiting
HIV Infections; Pneumococcal Infections
- Vaccine Therapy in Treating Patients With Metastatic Solid Tumors
ClinicalTrials.gov Identifier: NCT00030693 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment
ClinicalTrials.gov Identifier: NCT00138385 - Active, not recruiting
Influenza
- Safety and Immunogenicity of Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants.
ClinicalTrials.gov Identifier: NCT00130832 - Active, not recruiting
Rotavirus disease
- Vaccine Therapy in Treating Patients With Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00128583 - Active, not recruiting
stage III melanoma
- Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents
ClinicalTrials.gov Identifier: NCT00091702 - Active, not recruiting
HIV Infections; Influenza
- Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever
ClinicalTrials.gov Identifier: NCT00125008 - Active, not recruiting
Typhoid; Paratyphoid Fever
- Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy Subjects
ClinicalTrials.gov Identifier: NCT00189943 - Completed
Smallpox
- Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China
ClinicalTrials.gov Identifier: NCT00131833 - Active, not recruiting
Typhoid; Paratyphoid Fever
- Safety of and Immune Response to a DNA HIV Vaccine Followed By an Adenoviral Vector HIV Vaccine in Healthy Adults
ClinicalTrials.gov Identifier: NCT00125970 - Active, not recruiting
HIV Infections
- CDC Anthrax Vaccine Clinical Trial
ClinicalTrials.gov Identifier: NCT00119067 - Active, not recruiting
Healthy
- Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)
ClinicalTrials.gov Identifier: NCT00389103 - Terminated
Smallpox; Atopic Dermatitis
- Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue
ClinicalTrials.gov Identifier: NCT00131820 - Active, not recruiting
Typhoid; Paratyphoid Fever
- Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents
ClinicalTrials.gov Identifier: NCT00325130 - Active, not recruiting
Neoplasms, Glandular and Epithelial; Diphtheria; Tetanus; Whooping Cough; Meningitis
- Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents
ClinicalTrials.gov Identifier: NCT00141999 - Active, not recruiting
Hepatitis
- Vaccine Therapy in Treating Patients With Primary Stage II Melanoma
ClinicalTrials.gov Identifier: NCT00005052 - Active, not recruiting
stage II melanoma
- Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine
ClinicalTrials.gov Identifier: NCT00164411 - Active, not recruiting
Pneumococcal Infections
- Study to Evaluate Four Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as One Dose to Children Aged 12 to 14 Months and 3 to 5 Years Old
ClinicalTrials.gov Identifier: NCT00126984 - Active, not recruiting
Meningitis, Meningococcal
- Vaccine Therapy for Patients with Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00052156 - Active, not recruiting
Malignant Melanoma
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00087373 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- An Investigational Combination Vaccine Given to People Who Are Not Infected with HIV
ClinicalTrials.gov Identifier: NCT00027365 - Active, not recruiting
HIV Infections; HIV Seronegativity
- Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00003761 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00016146 - Active, not recruiting
recurrent prostate cancer
- Influenza Vaccine in Pediatric Transplant Subjects
ClinicalTrials.gov Identifier: NCT00133510 - Active, not recruiting
Influenza
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00022568 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Immunotherapy in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00003432 - Active, not recruiting
stage IV breast cancer
- Vaccine Therapy in Preventing Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants
ClinicalTrials.gov Identifier: NCT00128661 - Active, not recruiting
Cervical Cancer; high-grade squamous intraepithelial lesion
- A Study to Test 2 Doses of GSK Biologicals'' Oral Live Attenuated Human Rotavirus (HRV) Vaccine Given Concomitantly with Routine EPI Vaccinations Including OPV in Healthy Infants.
ClinicalTrials.gov Identifier: NCT00139347 - Active, not recruiting
Prophylaxis rotavirus
- Vaccine Therapy Plus Biological Therapy in Treating Patients With Relapsed Prostate Cancer
ClinicalTrials.gov Identifier: NCT00016120 - Active, not recruiting
recurrent prostate cancer
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00089206 - Active, not recruiting
intraocular melanoma; Melanoma
- Immunotherapy of Melanoma Patients
ClinicalTrials.gov Identifier: NCT00112216 - Recruiting
Melanoma
- Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood
ClinicalTrials.gov Identifier: NCT00125047 - Active, not recruiting
Typhoid; Paratyphoid Fever
- Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence
ClinicalTrials.gov Identifier: NCT00030823 - Active, not recruiting
Breast Cancer; Male Breast Cancer
- Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00004052 - Active, not recruiting
relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
- Vaccine Therapy in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00003665 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00010127 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate
- Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients
ClinicalTrials.gov Identifier: NCT00112229 - Recruiting
Melanoma
- A Dose-Escalation Vaccine Trial In HER2-Overexpressing Patients With High-Risk Breast Cancer
ClinicalTrials.gov Identifier: NCT00058526 - Active, not recruiting
Breast Cancer
- Consistency Lots Vaccine Study
ClinicalTrials.gov Identifier: NCT00092456 - Active, not recruiting
Rotavirus Infections
- Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities
ClinicalTrials.gov Identifier: NCT00311649 - Active, not recruiting
Influenza
- Immunologic Memory (Supp. of ATN 024)
ClinicalTrials.gov Identifier: NCT00142753 - Active, not recruiting
Healthy subjects; HIV Infection
- A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years
ClinicalTrials.gov Identifier: NCT00006509 - Active, not recruiting
HIV Infections
- Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00089219 - Active, not recruiting
intraocular melanoma; Melanoma
- A Study in Infants to Test Two Preparations (Freeze-Dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).
ClinicalTrials.gov Identifier: NCT00382772 - Active, not recruiting
Gastroenteritis
- A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group
ClinicalTrials.gov Identifier: NCT00000815 - Active, not recruiting
HIV Infections; Measles
- Vaccine Therapy in Treating Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00052988 - Active, not recruiting
stage I melanoma; stage II melanoma; stage III melanoma
- An Investigational Vaccine in Reducing the Incidence of Anogenital Warts in Young Men
ClinicalTrials.gov Identifier: NCT00090285 - Active, not recruiting
Condylomata Acuminata
- Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata
ClinicalTrials.gov Identifier: NCT00119197 - Active, not recruiting
Cholera
- A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age
ClinicalTrials.gov Identifier: NCT00092391 - Active, not recruiting
Measles; Mumps; Rubella; Varicella
- Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy
ClinicalTrials.gov Identifier: NCT00048386 - Active, not recruiting
Neuroblastoma
- A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chicken Pox)
ClinicalTrials.gov Identifier: NCT00130793 - Active, not recruiting
Herpes Zoster
- Vaccine Therapy in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00033228 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy for Patients with Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00052130 - Active, not recruiting
Malignant Melanoma
- Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00003222 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Vaccine Therapy with Or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, Or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00118313 - Active, not recruiting
stage II melanoma; stage III melanoma; Stage IV Melanoma
- Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children with Weakened Immune Systems
ClinicalTrials.gov Identifier: NCT00006066 - Active, not recruiting
HIV Infections
- Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00039325 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Safety, Tolerability, and Immunogenicity Study of a C Difficile Toxoid Vaccine in Healthy Adult Volunteers
ClinicalTrials.gov Identifier: NCT00127803 - Active, not recruiting
Clostridium Difficile
- Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00036933 - Active, not recruiting
stage III prostate cancer; recurrent prostate cancer
- A Study to Evaluate the Safety, Immune Response, and Efficacy of an Investigational Vaccine in Women
ClinicalTrials.gov Identifier: NCT00090220 - Active, not recruiting
Healthy; Papillomavirus Infection
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
